CIK 0001027838 · Accelerated filer
TACTILE SYSTEMS TECHNOLOGY INC
Sign in to watch- Ticker
- TCMD
- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- MN
- Entity type
- operating
- Phone
- 866-435-3948
- Business address
- 1331 TYLER STREET NE STE 200, MINNEAPOLIS, MN, 55413
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $255,000
- in 2 filings, $255K under 10b5-1 plans
Net −$255,000. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-07 | Asbury Valerie L. Director | Grant or award | +16,078 | 48,822 | ||
| 2025-05-07 | Huggenberger Raymond Director | Grant or award | +16,078 | 56,320 | ||
| 2025-05-07 | King Laura G. Director | Grant or award | +16,078 | 19,048 | ||
| 2025-05-07 | Shafer David Brent Director | Grant or award | +16,078 | 48,822 | ||
| 2025-05-07 | Volkart Carmen B Director | Grant or award | +16,078 | 37,698 | ||
| 2025-05-07 | Washington Boyd Vindell Director | Grant or award | +16,078 | 35,247 | ||
| 2025-03-11 | REUVERS DANIEL L. Director | Gift | −68,162 | 146,442 | ||
| 2025-03-11 | REUVERS DANIEL L. Director | Gift | +68,162 | 68,162 | ||
| 2025-02-25 | Birkemeyer Elaine M. Chief Financial Officer | Sale 10b5-1 | −2,066 | $14.51 | $30K | 102,032 |
| 2025-02-25 | Burns Kristie Sr. VP Mktg & Clinical Affairs | Sale | −6,468 | $14.40 | $93K | 77,540 |
| 2025-02-25 | REUVERS DANIEL L. Director | Sale 10b5-1 | −28,338 | $14.18 | $402K | 214,604 |
| 2025-02-24 | REUVERS DANIEL L. Director | Sale 10b5-1 | −10,938 | $14.55 | $159K | 242,942 |
| 2025-02-24 | Burns Kristie Sr. VP Mktg & Clinical Affairs | Sale | −4,830 | $14.65 | $71K | 84,008 |
| 2025-02-24 | Birkemeyer Elaine M. Chief Financial Officer | Sale 10b5-1 | −3,778 | $14.70 | $56K | 104,098 |
| 2025-02-20 | REUVERS DANIEL L. Director | Grant or award 10b5-1 | +15,853 | 253,880 | ||
| 2025-02-20 | Burns Kristie Sr. VP Mktg & Clinical Affairs | Grant or award | +3,359 | 68,128 | ||
| 2025-02-20 | Burns Kristie Sr. VP Mktg & Clinical Affairs | Grant or award | +4,131 | 72,259 | ||
| 2025-02-20 | Burns Kristie Sr. VP Mktg & Clinical Affairs | Grant or award | +16,579 | 88,838 | ||
| 2025-02-20 | Birkemeyer Elaine M. Chief Financial Officer | Grant or award 10b5-1 | +3,446 | 64,741 | ||
| 2025-02-20 | Birkemeyer Elaine M. Chief Financial Officer | Grant or award 10b5-1 | +6,887 | 71,628 |
Page 3 of 8 · 141 trades